Hikma Pharmaceutical | Salg



Sales Lave om Dato
Almirall EUR 248.42M 382K 2024-06
argenx SE USD 671.52M 129.45M 2024-12
AstraZeneca USD 14.89B 1.32B 2024-12
Autolus Therapeutics Ltd 187.5K 9.9M 2024-09
Bayer EUR 11.73B 1.76B 2024-12
Fresenius EUR 5.5B 130M 2024-12
Galapagos EUR 75.85M 16M 2024-12
Genmab DKK 64.41B 58.87B 2024-12
GlaxoSmithKline GBP 8.12B 108M 2024-12
GRIFOLS EUR 1.94B 150M 2024-12
Hikma Pharmaceutical USD 1.57B 121M 2024-06
Lonza CHF 3.52B 460M 2024-12
Merck EUR 5.42B 152M 2024-12
Orion EUR 434.4M 36.9M 2024-12
Recordati EUR 583.6M 26.19M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 10.56B 2.88B 2024-12
UCB EUR 3.36B 572M 2024-12



Hikma Pharmaceutical Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.